|Bid||15.15 x 1500|
|Ask||17.90 x 100|
|Day's Range||15.50 - 17.40|
|52 Week Range||4.45 - 19.90|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
On a per-share basis, the San Carlos, California-based company said it had a loss of 36 cents. Losses, adjusted for stock option expense, came to 32 cents per share. The results met Wall Street expectations. ...
Lion Biotechnologies (IOVA) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.
Iovance Biotherapeutics Inc (NASDAQ:IOVA), a $1.45B small-cap, operates in the healthcare industry, which faces demand for new drug development to meet new or persistent chronic illnesses, and ongoing need forRead More...
On a per-share basis, the San Carlos, California-based company said it had a loss of 37 cents. Losses, adjusted for stock option expense, came to 32 cents per share. The results surpassed Wall Street expectations. ...